The St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical-Biological Agency (FMBA) has filed an application with the Health Ministry...
Longidaza®, developed in Russia, received a patent in India. This was reported by the company "Petrovax". Thus, Longidasa, which already has patents in a...
The resident of SEZ Technopolis Moscow plans to complete the construction of a new large pharmaceutical production at Alabushevo site this year. The enterprise...
Promomed Group received marketing authorization certificate for a medicinal product with nadroparin calcium as active ingredient. Nadroparin is a low molecular weight heparin. It...